Dr. Dickson is the Vassar Woolley Professor of Chemistry & Biochemistry and has been at Georgia Tech since 1998. He was a Senior Editor of The Journal of Physical Chemistry from 2010-2021, and his research has been continuously funded (primarily from NIH) since 2000. Dr. Dickson has developed quantitative bio imaging and signal recovery/modulation schemes for improved imaging of biological processes and detection of medical pathologies. His work on fluorescent molecule development and photoswitching of green fluorescent proteins was recognized as a key paper for W.E. Moerner’s 2014 Nobel Prize in Chemistry. Recently, Dr. Dickson’s lab has developed rapid susceptibility testing of bacteria causing blood stream infections. Their rapid recovery methods, coupled with rigorous multidimensional statistics and machine learning have led to very simple, highly accurate and fast methods for determining the appropriate treatment within a few hours after positive blood cultures. These hold significant potential for drastically improving patient outcomes and reducing the proliferation of antimicrobial resistance.

The Curtis lab is primarily focused on the physics of cell-cell and cell-extracellular matrix interactions, in particular within the context of glycobiology and immunobiology. Our newest projects focus on questions of collective and single cell migration in vitro and in vivo; immunophage therapy "an immunoengineering approach - that uses combined defense of immune cells plus viruses (phage) to overcome bacterial infections"; and the study of the molecular biophysics and biomaterials applications of the incredible enzyme, hyaluronan synthase. A few common scientific themes emerge frequently in our projects: biophysics at interfaces, the use of quantitative modeling, collective interactions of cells and/or molecules, cell mechanics, cell motility and adhesion, and in many cases, the role of bulky sugars in facilitating cell integration and rearrangements in tissues.

Julie Champion is the William R. McLain Endowed Term Professor in the School of Chemical and Biomolecular Engineering at Georgia Institute of Technology. She earned her B.S.E. in chemical engineering from the University of Michigan and Ph.D. in chemical engineering at the University of California Santa Barbara. She was an NIH postdoctoral fellow at the California Institute of Technology. Champion is a fellow of the American Institute for Medical and Biological Engineering and has received awards including American Chemical Society Women Chemists Committee Rising Star, NSF BRIGE Award, Georgia Tech Women in Engineering Faculty Award for Excellence in Teaching, Georgia Tech BioEngineering Program Outstanding Advisor Award. Professor Champion’s current research focuses on design and self-assembly of functional nanomaterials made from engineered proteins for applications in immunology, cancer, and biocatalysis.

Jaydev P. Desai, Ph.D, is currently a Professor and BME Distinguished Faculty Fellow in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech. Prior to joining Georgia Tech in August 2016, he was a Professor in the Department of Mechanical Engineering at the University of Maryland, College Park (UMCP). He completed his undergraduate studies from the Indian Institute of Technology, Bombay, India, in 1993. He received his M.A. in Mathematics in 1997, M.S. and Ph.D. in Mechanical Engineering and Applied Mechanics in 1995 and 1998 respectively, all from the University of Pennsylvania. He was also a Post-Doctoral Fellow in the Division of Engineering and Applied Sciences at Harvard University. He is a recipient of several NIH R01 grants, NSF CAREER award, and was also the lead inventor on the "Outstanding Invention of 2007 in Physical Science Category" at the University of Maryland, College Park. He is also the recipient of the Ralph R. Teetor Educational Award. In 2011, he was an invited speaker at the National Academy of Sciences "Distinctive Voices" seminar series on the topic of "Robot-Assisted Neurosurgery" at the Beckman Center. He was also invited to attend the National Academy of Engineering's 2011 U.S. Frontiers of Engineering Symposium. He has over 150 publications, is the founding Editor-in-Chief of the Journal of Medical Robotics Research, and Editor-in-Chief of the Encyclopedia of Medical Robotics (currently in preparation). His research interests are primarily in the area of image-guided surgical robotics, rehabilitation robotics, cancer diagnosis at the micro-scale, and rehabilitation robotics. He is a Fellow of the ASME and AIMBE.

Dr. Yeo holds the titles of G.P. "Bud" Peterson and Valerie H. Peterson Endowed Professor, as well as Harris Saunders Jr. Endowed Professor, in the Woodruff School of Mechanical Engineering and the Coulter Department of Biomedical Engineering at Georgia Tech. He is also the director of the Wearable Intelligent Systems and Healthcare Center (WISH Center) and the KIAT-Georgia Tech Semiconductor Electronics Center (K-GTSEC). Dr. Yeo's research focuses on understanding the fundamentals of soft materials, deformable mechanics, interfacial physics, manufacturing, and the integration of hard and soft materials for the development of biomedical systems. He earned his Ph.D. in mechanical engineering and genome sciences from the University of Washington in Seattle and subsequently worked as a postdoctoral research fellow at the University of Illinois at Urbana-Champaign. With over 180 peer-reviewed publications, Dr. Yeo has contributed to many prestigious journals, including Nature Materials, Nature Machine Intelligence, Nature Communications, and Science Advances. He is an IEEE Senior Member and has received numerous awards, including the Visiting Professorship from the Institute Jean Lamour at the Université de Lorraine in France, the Lucy G. Moses Lectureship Award at the Mount Sinai School of Medicine, the NIH Trailblazer Young Investigator Award, the IEEE Outstanding Engineer Award, the Emory School of Medicine Research Award, the Imlay Innovation Award, the American Heart Association Innovative Project Award, the Sensors Young Investigator Award, the Med-X Young Investigator Award, and the Outstanding Service Award from the Korea Institute for Advancement of Technology, as well as the Outstanding Yonsei Scholar Award. Dr. Yeo is also the founder of two startup companies: Huxley Medical, Inc. and WisMedical, Inc.

Kyle Allison is a bioengineer and chemical engineer whose research has focused on understanding the behavior of bacteria in order to improve antibiotics. The Allison Lab tracks individual bacteria using microscopy approaches they developed.  Kyle and his lab have made foundational discoveries in the metabolite potentiation of antibiotics, the resuscitation of persistent bacteria, and the multicellularity of E. coli (the best-studied unicellular organism).  Kyle was named to the first “30 under 30” list in Science by Forbes Magazine and received the NIH Director’s Early Independence Award to bypass traditional postdoctoral training. His research has been published in Nature, PNAS, Molecular Systems Biology, Nature Methods, Nature Chemical Biology, and other journals.  Kyle also holds a master’s degree in literature and wrote his thesis on James Joyce’s Finnegans Wake.

Amirali Aghazadeh is an Assistant Professor in the School of Electrical and Computer Engineering and also program faculty of Machine Learning, Bioinformatics, and Bioengineering Ph.D. programs. He has affiliations with the Institute for Data Engineering and Science (IDEAS) and Institute for Bioengineering and Biosciences. Before joining Georgia Tech, Aghazaeh was a postdoc at Stanford and UC Berkeley and completed his Ph.D. at Rice University. His research focuses on developing machine learning and deep learning solutions for protein and small molecular design and engineering.
 

Vinny is an Assistant Professor at Georgia Tech with joint appointments at the School of Chemistry and Biochemistry and School of Biological Sciences.

A majority of antibiotics and drugs that we use in the clinic are derived or inspired from small organic molecules called Natural Products that are produced by living organisms such as bacteria and plants. Natural Products are at the forefront of fighting the global epidemic of antibiotic resistant pathogens, and keeping the inventory of clinically applicable pharmaceuticals stocked up. Some Natural Products are also potent human toxins and pollutants, and we need to understand how these toxins are produced to minimize our and the environmental exposure to them.

We as biochemists ask some simple questions- how and why are Natural Products produced in Nature, what we can learn from Natural Product biosynthetic processes, and how we can exploit Nature's synthetic capabilities for interesting applications?

Broadly, we are interested in questions involving (meta)genomics, biochemistry, structural and mechanistic enzymology, mass spectrometry, analytical chemistry, and how natural product chemistry dictates biology.

Alex Adams’s research focuses on designing, fabricating, and implementing new ubiquitous and wearable sensing systems. In particular, he is interested in how to develop these systems using equity-driven design principles for healthcare. Alex leverages sensing, signal processing, and fabrication techniques to design, deploy, and evaluate novel sensing technologies.

Originally a musician, Alex became fascinated by how he could capture and manipulate sounds through analog hardware and digital signal processing, which led him back to his hometown (Concord, NC). Alex completed his BS at the University of North Carolina at Charlotte in 2014 and his Ph.D. at Cornell University in 2021 (advised by Professor Tanzeem Choudhury). Alex then became the resident Research Scientist for the Precision Behavioral Health Initiative at Cornell Tech (NYC) until the fall of 2022, when he joined the School of Interactive Computing at the Georgia Institute of Technology. Currently, his research focuses on the equity-driven design and the development of multi-modal sensing systems to simultaneously assess mental and physical health to enable a new class of mobile health technologies.